Quick guide to anaphylaxis. (2020)

• Record Type: Book
• Further Information: Note: Cemal Cingi, Nuray Bayar Muluk.
• Other Names: Cingi, Cemal; Muluk, Nuray Bayar
• Contents: Intro -- Preface -- Contents -- About the Authors -- Chapter 1: Anaphylaxis: Definition, History, and Epidemiology -- 1.1 Definition of Anaphylaxis -- 1.2 History -- 1.3 Epidemiology of Anaphylaxis -- References -- Chapter 2: The Aetiology of Anaphylaxis -- 2.1 Food Allergy -- 2.1.1 Background -- 2.1.2 Definition of Food Allergy -- 2.1.3 Epidemiology -- 2.1.3.1 Sex- and Age-Related Demographics -- 2.1.4 Aetiology -- 2.1.4.1 IgE Antibody-Mediated Responses -- 2.1.4.2 Cell-Mediated Responses -- 2.1.5 Symptoms of Food Allergy -- 2.1.6 Food Allergy Triggers -- 2.1.7 Diagnosing Food Allergies 2.1.8 Characteristics of Food Allergens -- 2.1.9 Risk Factors -- 2.1.10 Management and Treatment -- 2.1.10.1 Investigational Therapeutic Interventions for Food Allergy -- 2.1.10.2 Patient Education -- Preparation -- Avoidance of Allergens -- 2.1.11 Anaphylaxis -- 2.1.12 Food Allergy Action Plan -- 2.1.13 Prognosis -- 2.2 Drug Allergy -- 2.2.1 Definition of Drug Allergy -- 2.2.2 Classification of Drug Allergy -- 2.2.3 Epidemiology -- 2.2.4 Drug Allergy and Anaphylaxis -- 2.2.5 Risk Factors for Drug Allergy -- 2.2.5.1 Drug-Related Factors -- 2.2.5.2 Factors Related to the Host 2.2.6 Genetics of Drug Allergy -- 2.2.7 History and Physical Examination -- 2.2.8 Diagnostic Tests -- 2.2.9 Specific Drugs and Biologic Agents and Drug Allergy -- 2.2.9.1 Antimicrobials -- 2.2.9.2 Insulin and Oral Antidiabetic Drugs -- 2.2.9.3 Cancer Chemotherapeutic Agents -- 2.2.9.4 Medications for Patients with HIV Infections and AIDS -- 2.2.9.5 Medications for Autoimmune Diseases -- 2.2.9.6 Perioperative Agents and Blood Products -- 2.2.9.7 Opiates -- 2.2.9.8 Corticosteroids -- 2.2.9.9 Heparin -- 2.2.9.10 Local Anaesthetics -- 2.2.9.11 Radio-Contrast Media -- 2.2.9.12 Biologic Modifiers 2.3 Venom Allergy -- 2.3.1 Background -- 2.3.2 Pathophysiology -- 2.3.3 Epidemiology -- 2.3.4 Symptoms -- 2.3.4.1 Local Reactions -- 2.3.4.2 Generalised Reactions -- 2.3.5 Diagnosis -- 2.3.6 Prognosis -- 2.3.7 Treatment -- 2.3.7.1 Emergency Department Care -- Epinephrine (Adrenalin, Bronitin, EpiPen) -- Bronchodilators -- Salbutamol (Ventolin) -- Antihistamines -- Systemic Corticosteroids -- Anti-tetanus Immunoglobulin -- 2.3.7.2 Desensitisation (Immunotherapy) -- Mechanism of immunotherapy -- 2.4 Allergic Rhinitis, Asthma, and Anaphylaxis -- 2.4.1 Background -- 2.4.2 Asthma and Anaphylaxis 2.4.2.1 Pathophysiology -- Inflammation Occurring Within Airways -- Discontinuous Blockage of Air Entry and Exit -- Overreactive Bronchi -- 2.4.2.2 Aetiology -- 2.4.2.3 Manifestations of an Acute Episode -- Mild Episodes -- Moderate Severity -- High Severity -- Pre-respiratory Arrest -- 2.4.2.4 Symptoms of an Asthma Emergency -- 2.4.2.5 Incidence of Anaphylactic Shock in Asthma -- 2.4.3 Allergic Rhinitis and Anaphylaxis -- 2.4.3.1 Pathophysiology -- 2.4.3.2 Symptoms and Chronicity -- 2.4.3.3 Trigger Factors -- 2.4.3.4 Comorbid Conditions -- 2.4.3.5 Mortality/Morbidity
• Publisher Details: Cham : Springer
• Publication Date: 2020
• Extent: 1 online resource (272 pages)
• Subjects: 616.97/5; Anaphylaxis; Anaphylaxis; Electronic books
• Languages: English
• ISBNs: 9783030336394; 3030336395
• Related ISBNs: 9783030336387; 3030336387
• Notes: Note: Includes bibliographical references.; Note: Print version record.
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.